Foundayo (orforglipron): price and where to get it online (2026)
Verified August 14, 2026: Foundayo (orforglipron) is Eli Lilly's FDA-approved once-daily oral GLP-1 pill, approved April 1, 2026. LillyDirect self-pay is dose-dependent: $149/mo at 0.8 mg; $199/mo at 2.5 mg; $299/mo at 5.5 mg or 9 mg; $299/mo at 14.5 mg or 17.2 mg when refilled within 45 days, otherwise $349/mo. We compare 6 telehealth sources plus LillyDirect below; provider program prices may include different services and are not necessarily the medication total.
What is Foundayo (orforglipron)?
Foundayo is the brand name. Orforglipron is the generic drug name. They are the same medicine.
Foundayo is Eli Lilly's once-daily oral GLP-1 receptor agonist. Unlike Ozempic, Wegovy, or Zepbound, it is a non-peptide small molecule. That structure survives stomach acid, so it works as a pill with no injection and no meal-timing fast.
The FDA approved Foundayo on April 1, 2026 for chronic weight management in adults with BMI ≥30, or BMI ≥27 with a weight-related condition. Commercial launch followed April 6, 2026.
In the ATTAIN-1 Phase 3 trial (N=1,401, 72 weeks, NEJM), Foundayo produced 12.4% mean body weight loss versus 2.3% for placebo. It is the first FDA-approved non-peptide oral GLP-1 for weight loss.
The UK authorised orforglipron on August 10, 2026, and for two indications, not one. The MHRA's own announcement is titled "UK first in Europe to authorise orforglipron for weight management and type 2 diabetes." Most coverage that reached US readers four to six days later framed it as Europe's first weight-loss pill approval and dropped the diabetes half. Two corrections worth carrying: this is a UK authorisation and not an EU one, so it says nothing about EMA timing; and it does not change what Foundayo is approved for in the United States, where the FDA indication remains chronic weight management only. A UK licence is not a US one, and asking a US prescriber for Foundayo to treat type 2 diabetes is an off-label request here regardless of what the MHRA authorised.
7.9/10 score. Men who want a well-known publicly-traded brand and FDA-approved Wegovy through the 2026 Novo Nordisk partnership, but should know going in that Hims' customer-experience signal is weaker than smaller competitors
Read our full Hims review →Where can I get Foundayo online?
These telehealth sources carry Foundayo (orforglipron), sorted by their program starting price. LillyDirect's medication ladder is $149/mo at 0.8 mg; $199/mo at 2.5 mg; $299/mo at 5.5 mg or 9 mg; $299/mo at 14.5 mg or 17.2 mg when refilled within 45 days, otherwise $349/mo. Provider totals can differ because of membership or consultation fees and insurance handling.
“Program from” is each provider's starting monthly price from our data file, not necessarily the Foundayo-specific price. Confirm the exact Foundayo cost on the provider's site.
| # | Source | Program From | Score | Type | Insurance | |
|---|---|---|---|---|---|---|
| 1 | Sesame Care #5 overall | published $99/mo; total not verified published month-to-month program fee; medication is separate, medication-inclusive total not verified | 7.9/10 | Both | Yes | Check Price |
| 2 | Found #31 overall | published $129/mo; total not verified headline under review; $49 membership + medication, $99/mo insured-path total; cash-pay total not verified | 7.3/10 | Both | Yes | Check Price |
| 3 | Ro #38 overall | $149/mo membership + medication | 7.2/10 | Brand | Yes | Check Price |
| 4 | Hims #7 overall | $188 first month, then $298/mo all-in floor for a $149 medication: $188 first month ($39 required Weight Loss Membership + $149 medication), then $298/mo ($149 membership + $149 medication); exact product and dose price varies | 7.9/10 | Brand | No | Check Price |
| 5 | Hers #30 overall | $188 first month, then $298/mo all-in floor for a $149 medication: $188 first month ($39 required Weight Loss Membership + $149 medication), then $298/mo ($149 membership + $149 medication); exact product and dose price varies | 7.3/10 | Both | No | Check Price |
| 6 | Shed #12 overall | from $199/mo | 7.8/10 | Both | No | Check Price |
Buy Foundayo direct from Eli Lilly (LillyDirect)
You can also order Foundayo through the manufacturer channel. LillyDirect self-pay is $149/mo at 0.8 mg; $199/mo at 2.5 mg; $299/mo at 5.5 mg or 9 mg; $299/mo at 14.5 mg or 17.2 mg when refilled within 45 days, otherwise $349/mo. The approved tablet sequence is 0.8 → 2.5 → 5.5 → 9 → 14.5 → 17.2 mg, with at least 30 days at each strength before any prescriber-directed increase. Foundayo is also dispensed through Amazon Pharmacy and GoodRx.
Visit LillyDirect →LillyDirect is the manufacturer's own pharmacy. This is an informational link, not an affiliate placement.
Foundayo vs the Wegovy pill vs compounded oral GLP-1
Three ways to take a GLP-1 by mouth in 2026. Only two are FDA-approved for weight loss.
| Factor | Foundayo (orforglipron) | Wegovy pill (semaglutide 25mg) | Compounded oral semaglutide |
|---|---|---|---|
| FDA-approved for weight loss | Yes (Apr 1, 2026) | Yes (Dec 2025) | No (not FDA-approved) |
| Phase 3 weight loss | 12.4% at 72 wks (ATTAIN-1) | 16.6% at 68 wks (OASIS) | No trial data |
| Fasting required | No | Yes (30-min pre-dose fast) | Varies by formulation |
| Lowest self-pay cost | ~$149/mo (LillyDirect starter) | From $149/mo cash, dose-dependent; $1,349/mo list | ~$199/mo |
| Structure | Non-peptide small molecule | Peptide (semaglutide) | Peptide (pharmacy-mixed) |
These percentages come from separate trials with different populations, designs, doses and follow-up periods: oral Wegovy reported 16.6% in OASIS, injectable semaglutide 14.9% in STEP-1 (NEJM), and tirzepatide 20.9% in SURMOUNT-1 (NEJM). They do not establish a class-wide oral-versus-injectable ranking or predict an individual result.
Compounded note: compounded oral semaglutide is not FDA-approved and has no dedicated trial data; bioavailability and quality vary by pharmacy. With two FDA-approved oral pills now available, the case for compounded oral semaglutide is weaker than it was in 2024-2025.
How much does Foundayo cost with insurance?
Foundayo's list price (WAC) is about $649/month. Most people pay far less.
With commercial insurance + Lilly's savings card: ~$25/month (the same copay structure as Zepbound). CVS Caremark added Foundayo to its standard commercial formulary effective June 1, 2026.
With Medicare: $50/month flat. As of July 1, 2026, Medicare Part D covers Foundayo at a $50 copay through the GLP-1 Bridge demonstration. See our Medicare GLP-1 Bridge guide for eligibility and how to enroll.
Paying cash through LillyDirect: $149/mo at 0.8 mg; $199/mo at 2.5 mg; $299/mo at 5.5 mg or 9 mg; $299/mo at 14.5 mg or 17.2 mg when refilled within 45 days, otherwise $349/mo. A prescription is required; confirm the strength and refill deadline before checkout.
Foundayo side effects (quick summary)
What are Foundayo's side effects?
Foundayo's most common side effects are gastrointestinal and mirror other GLP-1 drugs: nausea, diarrhea, constipation, and vomiting. In ATTAIN-1, symptoms were most frequent during dose escalation and eased at steady state.
This page is a pricing and access overview, not medical guidance. For dose-by-dose management protocols and red flags, read our full breakdown.
Foundayo side effects: full guide →Frequently Asked Questions
What is Foundayo?+
Is Foundayo the same as orforglipron?+
How much does Foundayo cost?+
Where can I get Foundayo online?+
Foundayo vs the Wegovy pill: which is better?+
Does Medicare cover Foundayo in 2026?+
Next step: read our full Hims review (the highest-scoring current Foundayo listing that meets the dated-tier eligibility above), or take the 2-minute match quiz to find the right GLP-1 program for you.